GlassScriptPhysician profile
Abid Hammed Khan
NPI 1326184524
$3,197.08
in general payments reported to CMS, 2019-2025
17 companies · $777 in 2025
The $777 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $102 · 2021: $466 · 2022: $356 · 2023: $611 · 2024: $524 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,887 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,887.45 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $718.95 | 2019-2025 | Vafseo, Auryxia |
| Astrazeneca Pharmaceuticals LP | $644.85 | 2019-2025 | Farxiga, Lokelma |
| Ardelyx, INC. | $560.51 | 2023-2025 | Ibsrela, Xphozah 30 Mg |
| Opko Pharmaceuticals, LLC | $309.90 | 2019-2024 | Rayaldee |
| Vifor Pharma, INC. | $218.95 | 2019-2023 | Veltassa, Korsuva |
| Travere Therapeutics, INC. | $164.13 | 2023-2024 | |
| Horizon Therapeutics Plc | $160.07 | 2020-2022 | |
| Cardiovascular Systems INC. | $107.98 | 2019 | |
| Fresenius USA Marketing, INC. | $100.43 | 2019-2024 | Velphoro |
| Otsuka America Pharmaceutical, INC. | $70.13 | 2019-2025 | Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $41.11 | 2023-2024 | |
| Scpharmaceuticals INC. | $30.10 | 2025 | |
| Amgen INC. | $27.31 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.46 | 2024 | Jardiance |
| Exact Sciences Corporation | $19.20 | 2025 | Cologuard Collection Kit |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abid Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.